Colin, Xavier; Lafuma, Antoine; Costagliola, Dominique; … - In: PharmacoEconomics 28 (2010) S1, pp. 59-68
Background: Highly active antiretroviral therapy (HAART) has greatly enhanced HIV management, lowering the risk of clinical disease progression and death by substantially improving HIV-induced immune deficiency. Lower CD4 cell counts have consistently been associated with higher direct costs of...